These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22307331)

  • 21. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis.
    Kolibianakis EM; Kalogeropoulou L; Griesinger G; Papanikolaou EG; Papadimas J; Bontis J; Tarlatzis BC
    Hum Reprod Update; 2007; 13(5):445-52. PubMed ID: 17586849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: A randomised controlled trial.
    Wang Z; Yang A; Bao H; Wang A; Deng X; Xue D; Tan H; Zhou Y; Wu C; Chen ZJ; Shi Y
    BJOG; 2022 Jun; 129(7):1030-1038. PubMed ID: 34882964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
    Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
    J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis.
    Coomarasamy A; Afnan M; Cheema D; van der Veen F; Bossuyt PM; van Wely M
    Hum Reprod; 2008 Feb; 23(2):310-5. PubMed ID: 18056719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Kyrou D; Kolibianakis EM; Venetis CA; Papanikolaou EG; Bontis J; Tarlatzis BC
    Fertil Steril; 2009 Mar; 91(3):749-66. PubMed ID: 18639875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment.
    Sunkara SK; Coomarasamy A
    Fertil Steril; 2011 Jun; 95(8):e73-4; author reply e75. PubMed ID: 21601849
    [No Abstract]   [Full Text] [Related]  

  • 33. Androgen supplementation in assisted reproduction: where are we in 2019?
    Montoya-Botero P; Rodriguez-Purata J; Polyzos NP
    Curr Opin Obstet Gynecol; 2019 Jun; 31(3):188-194. PubMed ID: 30855291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant luteinizing hormone priming in early follicular phase for women undergoing in vitro fertilization: systematic review and meta-analysis.
    Hu L; Bu Z; Wang K; Sun Y
    J Int Med Res; 2014 Apr; 42(2):261-9. PubMed ID: 24595152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
    Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
    Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.
    Fábregues F; Peñarrubia J; Creus M; Manau D; Casals G; Carmona F; Balasch J
    Hum Reprod; 2009 Feb; 24(2):349-59. PubMed ID: 19054777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
    Polyzos NP; Nwoye M; Corona R; Blockeel C; Stoop D; Haentjens P; Camus M; Tournaye H
    Reprod Biomed Online; 2014 Apr; 28(4):469-74. PubMed ID: 24581984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.